Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $14.3 million.

  • Connect Biopharma Holdings' Cash from Investing Activities rose 985918.37% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.9 million, marking a year-over-year change of. This contributed to the annual value of -$3.5 million for FY2024, which is 10460.26% down from last year.
  • Per Connect Biopharma Holdings' latest filing, its Cash from Investing Activities stood at $14.3 million for Q3 2025, which was up 985918.37% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Cash from Investing Activities registered a high of $14.3 million during Q3 2025, and its lowest value of -$20.6 million during Q1 2025.